Raheleh Salari is a prominent inventor based in San Carlos, CA (US). She has made significant contributions to the field of cancer detection and immune system monitoring. With a total of 6 patents, her work focuses on innovative methods that enhance the detection and monitoring of various cancers and immune cell populations.

Latest Patents

One of her latest patents involves methods for cancer detection and monitoring. This invention provides techniques for detecting single nucleotide variants in breast cancer, bladder cancer, or colorectal cancer. The methods include generating a set of amplicons through multiplex amplification reactions on nucleic acids isolated from blood or urine samples. This approach allows for the monitoring and detection of early relapse or metastasis of these cancers. Another significant patent focuses on detecting immune cell DNA and monitoring immune systems. This disclosure offers methods and compositions for detecting or monitoring immune cell populations in biological samples, particularly useful for patients undergoing treatment that results in immune cell depletion.

Career Highlights

Raheleh has worked with notable companies such as Natera, Inc. and UCL Business Plc. Her experience in these organizations has contributed to her expertise in the field of biotechnology and cancer research.

Collaborations

Throughout her career, Raheleh has collaborated with professionals like Bernhard Zimmermann and Ryan Swenerton. These collaborations have further enriched her research and development efforts.

Conclusion

Raheleh Salari is a trailblazer in the realm of cancer detection and immune monitoring. Her innovative patents and career achievements reflect her dedication to advancing medical technology and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.